Skip to main content

respiratory syncytial virus Archives

Study finds most infants receiving ICU-level care for RSV had no underlying medical condition

Aug. 15, 2023—A Vanderbilt study found that most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term.

Read more


Researchers discover antibody that neutralizes both RSV and hMPV

Aug. 4, 2023—Vanderbilt and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus and human metapneumovirus.

Read more


Study finds early RSV infection linked to significantly increased risk of asthma in children

Apr. 24, 2023—A Vanderbilt study has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children.

Read more


Study finds RSV may evade vaccines via rapid mutation

Mar. 9, 2023—A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.

Read more


Study explores role RSV plays in later asthma development

Jul. 21, 2022—A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development

Read more


Study finds azithromycin use during RSV not useful in preventing recurrent wheezing, may cause harm

Feb. 28, 2022—Vanderbilt research on the impact of the antibiotic azithromycin during severe respiratory syncytial virus (RSV) bronchiolitis overwhelmingly support current national bronchiolitis guidelines, which recommend against antibiotics during acute bronchiolitis due to lack of effect on the acute illness.

Read more


Pediatricians see spike in RSV cases, urge parents to be on lookout for symptoms

Jun. 23, 2021—“We are seeing a spike in respiratory illnesses, especially RSV (respiratory syncytial virus) and parainfluenza, which cause croup and bronchiolitis in young children and flu-like symptoms in older children and adults,” said James Antoon, MD, PhD, FAAP, assistant professor of Pediatrics at Children’s Hospital at Vanderbilt.

Read more


RSV transmission in the Middle East

Nov. 14, 2019—Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design.

Read more


Hope for an RSV vaccine

Feb. 23, 2018—Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design.

Read more


RSV-HRV viral interference

May. 15, 2017—RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants.

Read more


Research sheds light on how RSV wards off potential vaccines

Oct. 20, 2016—Respiratory syncytial virus (RSV) is the major cause of life-threatening viral pneumonia in infants worldwide, yet despite repeated efforts, scientists have been unable to develop an effective vaccine against it.

Read more


Study finds maternal diet may predict RSV severity

Mar. 4, 2013—An important predictor of the severity of respiratory syncytial virus (RSV) in infants may be what their mothers ate during pregnancy.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more